The health minister on Tuesday announced during a parliamentary discussion that India is most likely to start the vaccination process for children by the end of the next month or September. Health minister Mansukh Mandaviya reported this in the presence of our Honourable Prime Minister Mr. Narendra Modi.
The decision has been taken after considering the coming third wave of the deadly Coronavirus. It is being expected that the third wave is going to affect the children of the country, in that light it is important to vaccinate children before the wave arrives. Vaccinating children before the third wave will be an important step in breaking the chain of the virus.
Mansukh Mandaviya, the union health minister also said that India is going to become one of the world’s largest producers of vaccines after more companies get production licenses In India.
“Vaccinating children is a great decision as it will not only help prevent the virus spread but also help the government make decisions regarding calling the students back to school “AIIMS Chief Dr. Randeep Guleria.
Bharat Biotech’s Covid 19 vaccine Covaxin is under process, and the results are expected to be released by the end of August or September. Meanwhile, Zydus Cadila, a medicine producer, has also planned to provide vaccines for children Further, if Pfizer gets a green flag from the Government, then it will also be an option for children. However, many countries have already approved the Pfizer-BioNTech United States and Australia and Canada being one of them.
According to the report, most of the developing and developed countries have passed Pfizer- BioNTech vaccine for children above 12 only. Those countries like Germany, Poland, the USA, Lithuania, Romania, and other countries from the middle east and Europe have already started vaccinating their 12-year-old and above citizens against coronavirus. Where these countries are using Pfizer as a vaccine China has shown trust over Sinovac Biotech. this is for emergency use for children as young as age 3.
Meanwhile, Pfizer is planning to launch the vaccines for children under 5 to 11 after testing.
On Tuesday, the expert panel has asked the Serum Institute of India (SII) to go ahead with the 2/3 trial of Covaxin. This trial is being carried out for children ages 2 to 17.
The vaccine trial in India is being conducted in three phases. The first trial has started from age 12-18 and was followed by 6-12. The trial for the ages 2-6 is still in process.
Earlier this month, the health minister also confirmed the vaccine as being safe for pregnant women. Pregnant women can now be vaccinated by any one of the vaccines available in India- Covisheild, Covaxin, or Sputnik V. This decision was taken by keeping in mind the effect of the second wave.
According to experts, the vaccination program in India is going well. Currently, 44.2 crores citizens are partially vaccinated whereas 9.54 crores citizens are fully vaccinated, which accounts for 7% of our total population.
Share This Post On
Leave a comment
You need to login to leave a comment. Log-in